Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,753 public trials 646 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

First in Human of Single and Multiple Doses of MOR106

NCT02739009

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • SGS LSS Clinical Pharmacology Unit Antwerp, Belgium
  • St Johns Hospital Budapest, Hungary
  • • Arensia Phase I unit Chisinau, Moldova
  • Arensia Phase I unit Bucharest, Romania
View Trial Details
Completed

A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis

NCT02340234

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dermatology Research Associate Los Angeles, California, United States
  • UCSD Division of Dermatology San Diego, California, United States
  • Univ of Calif-San Francisco San Francisco, California, United States
  • University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 74 locations
View Trial Details
Completed

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

NCT01147744

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 84 locations
View Trial Details

Related conditions